Combination chemotherapy

The invention relates to a pharmaceutical composition, a therapeutic combination product and a kit comprising a sterically hindered platinum coordination compound and a non-platinum based anti-cancer agent and a pharmaceutically-acceptable carrier or diluent; to the use thereof for the manufacture o...

Full description

Saved in:
Bibliographic Details
Main Authors T.C. STEPHENS, M.P. SMITH
Format Patent
LanguageEnglish
Published 09.07.2003
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to a pharmaceutical composition, a therapeutic combination product and a kit comprising a sterically hindered platinum coordination compound and a non-platinum based anti-cancer agent and a pharmaceutically-acceptable carrier or diluent; to the use thereof for the manufacture of a medicament for inhibiting the growth of tumour cells in a human afflicted therewith; to a method of inhibiting the growth of tumour cells in a human afflicted therewith which comprises administering to such human an effective tumour cell growth inhibiting amount of such a therapeutic combination product or of a pharmaceutical composition of the invention; in particular when the sterically hindered platinum coordination compound is (SP-4-3)-(cis)-am-minedichloro-Ä2-methylpyridineÜplatinum (II), or a pro-drug thereof, and the non-platinum based anti-cancer agent is selected from Taxol Gemcitabine, Navelbine, Doxil, 5-FU and Taxotere.
AbstractList The invention relates to a pharmaceutical composition, a therapeutic combination product and a kit comprising a sterically hindered platinum coordination compound and a non-platinum based anti-cancer agent and a pharmaceutically-acceptable carrier or diluent; to the use thereof for the manufacture of a medicament for inhibiting the growth of tumour cells in a human afflicted therewith; to a method of inhibiting the growth of tumour cells in a human afflicted therewith which comprises administering to such human an effective tumour cell growth inhibiting amount of such a therapeutic combination product or of a pharmaceutical composition of the invention; in particular when the sterically hindered platinum coordination compound is (SP-4-3)-(cis)-am-minedichloro-Ä2-methylpyridineÜplatinum (II), or a pro-drug thereof, and the non-platinum based anti-cancer agent is selected from Taxol Gemcitabine, Navelbine, Doxil, 5-FU and Taxotere.
Author T.C. STEPHENS
M.P. SMITH
Author_xml – fullname: T.C. STEPHENS
– fullname: M.P. SMITH
BookMark eNrjYmDJy89L5WSQcM7PTcrMSyzJzM9TSM5Izc0vyUgtSiyo5GFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c5-hiZGloaGJo7GhFUAAFd3I4E
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 7
ExternalDocumentID CN1429114A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN1429114A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:14:56 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN1429114A3
Notes Application Number: CN20018009337
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030709&DB=EPODOC&CC=CN&NR=1429114A
ParticipantIDs epo_espacenet_CN1429114A
PublicationCentury 2000
PublicationDate 20030709
PublicationDateYYYYMMDD 2003-07-09
PublicationDate_xml – month: 07
  year: 2003
  text: 20030709
  day: 09
PublicationDecade 2000
PublicationYear 2003
RelatedCompanies ANOMED CO., LTD
RelatedCompanies_xml – name: ANOMED CO., LTD
Score 2.5720863
Snippet The invention relates to a pharmaceutical composition, a therapeutic combination product and a kit comprising a sterically hindered platinum coordination...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Combination chemotherapy
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030709&DB=EPODOC&locale=&CC=CN&NR=1429114A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQAXZwEk1NjZJ0E00s03RNjFINdZMM0ix1k5NMzAzNUo2TTcE7vH39zDxCTbwiTCOYGDJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGqx3DErBlmouTrauAf4u_s5qzs62zn5qfkG2hsByF9j0d2RmYAU1okGn7LuGOYH2pBQgVyhuggxsAUCz8kqEGJhS84QZOJ1h964JM3D4Qqe7gUxozisWYZAAZlxgJxbsNAVgQOdCd05VijLIu7mGOHvoAq2Ih_sm3tkP5hZjMQYWYB8_VYJBwQJYZ1iaGCcCOy_JJolGaZYGZomWhmlGieYGqRYppimSDBK4TJHCLSXNwAVeewYajbSUYWApKSpNlQXWoSVJcmDvAwBGJ3Ue
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQAXZwEk1NjZJ0E00s03RNjFINdZMM0ix1k5NMzAzNUo2TTcE7vH39zDxCTbwiTCOYGDJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGqx3DErBlmouTrauAf4u_s5qzs62zn5qfkG2hsByF9j0d2RmYDUHnc0LajiFOYH2pBQgVyhuggxsAUCz8kqEGJhS84QZOJ1h964JM3D4Qqe7gUxozisWYZAAZlxgJxbsNAVgQOdCd05VijLIu7mGOHvoAq2Ih_sm3tkP5hZjMQYWYB8_VYJBwQJYZ1iaGCcCOy_JJolGaUAXJloaphklmhukWqSYpkgySOAyRQq3lDwDp0eIr0-8j6eftzQDF3gdGmhk0lKGgaWkqDRVFlifliTJgYMCAOeweAs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Combination+chemotherapy&rft.inventor=T.C.+STEPHENS&rft.inventor=M.P.+SMITH&rft.date=2003-07-09&rft.externalDBID=A&rft.externalDocID=CN1429114A